Fully understand the similarities and differences in filing document requirements and innovative drug accelerated approval channels among global regulatory authorities such as China, US, Europe and more, provide product targeted registration clinical global development strategy.
Provides tailored CMC regulatory strategies based on the development patterns of innovative drugs at different stages, guiding pharmaceutical development plans to ensure regulatory compliance and R&D efficiency.
IND and NDA CMC filing document writing
Writing of Module 2.4 and 2.6
China and US meeting application document writing
DMF/ASMF/CEP/MF filing document writing
Writing of pharmaceutical supplemental applications and annual reports during clinical period
Writing of post marketing product pharmaceutical supplemental applications, record filing applications and annual reports
Provide regulatory support for GXP audits
Inspection application document preparation
Assist in receiving on site inspections and unannounced inspections
China: clinical trial application, supplemental application, marketing application, raw material and excipient record filing, breakthrough therapy application, communication meetings and more
China official qualification and license application: such as drug production license, EU export certificate, export sales certificate, one time import approval and more
US: clinical trial application, marketing application, DMF filing, INTERACT meeting, Type B and C meetings, orphan drug designation application, breakthrough therapy application, IND maintenance, DSUR submission, SUSAR submission and more
Europe: CEP/MF filing and more
eCTD publishing
The team has delivered filing document writing and registration submission work for over 100 China and US IND and NDA projects for clients, completed document preparation and successful filing for multiple US and Europe DMF and ASMF projects.
Comprehensive and flexible multi channel communication channels, capable of consultation and communication on technical and regulatory issues.
Asymchem has its own team of expert consultants, providing clients with professional consulting services across multiple dimensions, including technology development, regulatory affairs, and review strategy.
Core members of the regulatory team have more than a decade of drug registration experience and excellent project management capabilities.
Familiar with non clinical, CMC and clinical research related regulatory requirements and drug filing processes, meeting clients' filing strategy needs.